Enhanced Insulin Delivery Rate Adjustment System

An advanced system for adjusting insulin delivery rates, incorporating machine learning and real-time glucose data analysis to optimize insulin delivery for individuals with diabetes.

The original patent, 'Adjusting insulin delivery rates', addressed the need for personalized insulin delivery. However, it had limitations in terms of predicting future glucose levels, handling fear of hypoglycemia, and adapting to changing glucose trends. The new inventive concept builds upon the original patent, providing enhanced features to overcome these limitations.

The system comprises a glucose measurement device, a processor, and a controller. The processor predicts multiple future blood glucose levels for multiple different basal insulin delivery profiles, and the controller selects the optimal profile that minimizes differences between predicted future blood glucose values and target blood glucose values. The system can also receive glucose data, calculate a probability of achieving a target blood glucose level, and select an optimal basal insulin delivery profile based on the calculated probability. Additionally, the system can obtain a fear of hypoglycemia index from a user, calculate a personalized basal insulin delivery rate, and deliver insulin accordingly. The system can adapt to changing glucose trends by identifying trends in glucose data and adjusting the basal insulin delivery rate in real-time.

The new inventive concept introduces the use of machine learning algorithms to predict multiple future blood glucose levels, enabling the selection of an optimal basal insulin delivery profile. The system's ability to adapt to changing glucose trends and incorporate fear of hypoglycemia indices into insulin delivery decisions are also novel and non-obvious improvements over the original patent.

Alternative embodiments of the system could include using different machine learning algorithms, incorporating additional health metrics (e.g., exercise, diet), or integrating with wearable devices. Variations could include implementing the system in different form factors, such as a mobile app or a dedicated device.

The enhanced insulin delivery rate adjustment system has significant commercial potential in the diabetes management industry, with potential applications in personalized medicine, real-time glucose monitoring, and artificial pancreas systems. The target market includes individuals with diabetes, healthcare providers, and medical device manufacturers.